mRNA is emerging as a promising platform in biopharmaceuticals due to its flexibility, safety, and precision compared to traditional methods of vaccine development and therapeutic protein production. An increasing number of clinical trials in various therapies reflect growing industry interest in bringing these vaccines to market. They offer the advantage of rapid, large-scale manufacturing suitable for clinical applications, making them ideal for responding quickly to epidemic outbreaks.
The success of mRNA-based products has driven demand for scalable, clinical-grade manufacturing processes supported by robust analytical methods to ensure safety, potency, and purity. Sensors play a vital role in monitoring key parameters such as temperature, pH, oxygen level, pressure, and flow during production. Their integration into automated control systems enables prompt detection of deviations, enhancing process reliability, product consistency, and compliance with regulatory standards